TRex Bio
Latest round
- Series B
Last raised
- Jan 2026
Total raised
- $219M
Investors
- 14
About TRex Bio
Based in the US, TRex Bio, Inc.Founded in 2018 and headquartered in San Francisco, US, TRex Bio, Inc. specializes in innovative therapeutics targeting immune-mediated diseases. TRex Bio specializes in the development of innovative therapeutics for immune-mediated diseases through its proprietary human tissue-based Deep Biology Platform. This platform enables the company to analyze T regulatory (T reg) cell behavior within human tissues, linking dysregulation to various diseases. By utilizing advanced sequencing and computational tools alongside human assay systems, TRex Bio aims to identify and create therapeutics that can restore tissue homeostasis and mitigate inflammatory processes. The company’s scientific focus centers on harnessing a vast collection of human tissue samples, gathered from both healthy and diseased states, to inform their drug discovery pipeline.TRex Bio's revenue model is structured around partnerships and collaborations with pharmaceutical companies, as well as potential licensing agreements for its therapeutic candidates. Transactions typically involve collaborative research and development agreements, where clients invest in the development of specific therapeutics tailored to immune-mediated diseases. These partnerships allow for shared resources and expertise in the drug discovery process. In January 2026, TRex Bio, Inc.
Who invested in TRex Bio
14 investors across 4 rounds
See all investors in TRex Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TRex Bio
Who invested in TRex Bio?
TRex Bio has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TRex Bio raised?
TRex Bio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did TRex Bio last raise money?
TRex Bio's most recent round on record is a Series B, in Jan 2026.
What does TRex Bio do?
Based in the US, TRex Bio, Inc.
Where is TRex Bio headquartered?
TRex Bio is headquartered in San Francisco, US.
Which VCs invest in companies like TRex Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TRex Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TRex Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.